PLx Pharma Inc reports results for the quarter ended in September - Earnings Summary

PLx Pharma Winddown

11/11/2022 14:31

* PLx Pharma Inc  PLXP.OQ  reported a quarterly adjusted
loss
of 30 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 44 cents per share.
    * Revenue fell 94.2% to $386.00 thousand from a year ago;
analysts
expected $1.30 million. 
    * PLx Pharma Inc's reported EPS for the quarter was a loss
of 30
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * PLx Pharma Inc shares had fallen by 7.7% this quarter and
lost 92.5% so far this year.
    * The company reported a quarterly loss of $8.5 million.
    * Wall Street's median 12-month price target for PLx Pharma
Inc is
$11.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
11 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.44          -0.30          Beat
 Jun. 30 2022      -0.56          -0.43          Beat
 Mar. 31 2022      -0.72          -0.39          Beat
 Dec. 31 2021      -0.71          0.10           Beat